|
LOC285074 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.865700E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.619400E-01 |
| Normal-vs-Stage2 |
9.370300E-02 |
| Normal-vs-Stage3 |
3.336200E-01 |
| Normal-vs-Stage4 |
3.452000E-01 |
| Stage1-vs-Stage2 |
1.390980E-01 |
| Stage1-vs-Stage3 |
6.842000E-01 |
| Stage1-vs-Stage4 |
4.514400E-01 |
| Stage2-vs-Stage3 |
4.542400E-01 |
| Stage2-vs-Stage4 |
8.075600E-01 |
| Stage3-vs-Stage4 |
7.336800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.083420E-01 |
| Normal-vs-AfricanAmerican |
1.077170E-01 |
| Normal-vs-Asian |
2.463200E-01 |
| Caucasian-vs-AfricanAmerican |
6.862000E-01 |
| Caucasian-vs-Asian |
1.767780E-01 |
| AfricanAmerican-vs-Asian |
2.580800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.149350E-01 |
| Normal-vs-Female |
3.241600E-02 |
| Male-vs-Female |
2.738200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.932000E-01 |
| Normal-vs-Extreme_Weight |
2.638600E-01 |
| Normal-vs-Obese |
5.506400E-02 |
| Normal-vs-Extreme_Obese |
5.552200E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.046600E-01 |
| Normal_Weight-vs-Obese |
2.916600E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.559600E-01 |
| Extreme_Weight-vs-Obese |
3.023000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.001800E-01 |
| Obese-vs-Extreme_Obese |
3.653800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.599500E-02 |
| Normal-vs-Age(41-60Yrs) |
4.739300E-03 |
| Normal-vs-Age(61-80Yrs) |
5.510600E-01 |
| Normal-vs-Age(81-100Yrs) |
9.296000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.194200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.489500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.323000E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.016100E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.042700E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.248100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.375200E-03 |
| Normal-VS-Type2 PRCC |
2.192200E-01 |
| Normal-VS-KIRP CIMP |
1.643900E-03 |
| Normal-VS-Unclassified PRCC |
3.175600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.19940000001362E-06 |
| Type1 PRCC-VS-KIRP CIMP |
5.75360000000247E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
2.627600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.65989999102135E-09 |
| Type2 PRCC-VS-Unclassified PRCC |
2.694400E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.169400E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.780600E-01 |
| Normal-vs-N1 |
7.987900E-02 |
| Normal-vs-N2 |
7.890600E-01 |
| N0-vs-N1 |
5.769700E-02 |
| N0-vs-N2 |
7.492200E-01 |
| N1-vs-N2 |
5.243000E-01 |
|
|
